“…As reported previously, in mammals, CHD7 could be recruited at the promoters or superenhancers of the transcriptionally active region of specific genes to increase or decrease transcription 20 , 45 . Existing studies of CHD7 preferentially shed light on nervous system development and the differentiation of neural stem cells and neural crest stem cells, and CHD7 has been proven to be crucial for neurogenesis and adult neural stem cell maintenance 9 , 10 , 13 , 46 , 47 . Widely observed in clinical work, the alteration of CHD7 expression levels in specific cell lineages leads to severe malfunction or diseases, e.g., CHARGE syndrome, Kallmann syndrome, autism spectrum disorder, developmental disorders of multiple organ systems, and tumorigenesis 13 , 15 , 45 – 49 .…”